Pharmaceutical industry violations in the U.S. 1991-2017, by violation type

Total number of pharmaceutical industry violations in the U.S. between 1991 and 2017, by type of violation

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

March 2018


United States

Survey time period

1991 to 2017

Supplementary notes

* Since the publication of the 2016 report, an additional federal, non-qui-tam settlement with Syncor, in 2002 for $2.5 million ($0.5 million civil penalty; $2 million criminal penalty) for kickbacks, was found and added to the database.
** Poor manufacturing practices: selling drug products that fail to meet FDA standards or specifications (e.g., contaminated or adulterated products, or products that fail to meet size or dosage specifications).

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you Pharmaceutical and medical device recalls in the U.S.



Pharmaceutical product recalls


Digression: pharmaceutical violations


Medical device recalls


Medical devices- inspections and warnings


Further related statistics

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.